Pricing Log in Create free account

Cingulate Inc. (CING) vs Telomir Pharmaceuticals, Inc. (TELO)

Cingulate Inc. and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. Cingulate Inc. and Telomir Pharmaceuticals, Inc. are of similar size ($61.7M and $57.5M). Across the 9 metrics below, Cingulate Inc. leads on 7 and Telomir Pharmaceuticals, Inc. on 2.

Valuation

Metric CING TELO Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 2.39 9.43 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield (86.56%) (116.67%) (34.89%)
Free cash flow yield (37.36%) (10.36%) (24.52%)

Profitability

Metric CING TELO Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (198.74%) (1,885.50%) (50.12%)
Return on assets (123.76%) (1,678.31%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CING TELO Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 59.12% 41.07% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CING TELO Biotechnology median
Debt to equity 0.00 0.03 0.00
Current ratio 3.50 16.14 4.89
Net debt to EBITDA 0.51 0.69 1.01

Dividend

Metric CING TELO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CING TELO Biotechnology median
Market cap 61.66m 57.48m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack